Android app on Google Play

FDA panel votes 3-14 that Abbott (ABT) has not found right Humira dose

August 28, 2012 1:31 PM EDT Send to a Friend
FDA panel votes 3-14 that Abbott (NYSE: ABT) has not found right Humira dose.




You May Also Be Interested In


Related Categories

FDA, General News

Add Your Comment